News
New publication in PLOS ONE
04
Apr
Dr. Bérard has published a new article in the PLOS ONE, vol. 9, Issue 4 entitle: "The Quebec Pregnancy Cohort - Prevalence of Medication Use During Pregnancy and Pregnancy Outcomes." This article describes the Quebec Pregnancy Cohort and present his potential for perinatal research and the validity of the variables included in this cohort.
A new publication for Dr. Bérard in “International Innovation’’
03
Jan
Dr. Bérard has published a new article in the journal International Innovation, vol. 123. In the paper, ‘’Risky prescriptions”, Dr. Bérard shows the results of recent studies assessing the association between antidepressant use and negative birth outcomes. She also describes the Quebec Pregnancy Cohort and its potential for pharmacoepidemiological research on pregnancy and birth.
Dr. Bérard obtains a CIHR grant
04
Nov
Dr. Bérard has obtained a grant from the Canadian Institutes for Health Research (CIHR) to conduct a case-control study on the association between the use of SNRIs, bupropion, and mirtazapine and the risk of persistent pulmonary hypertension in the newborn. This study will be conducted using two Canadian databases (the Quebec Pregnancy Cohort and the Saskatchewan database) and an American database (US Medicaid Cohort).
Dr. Bérard has obtained a CIHR grant
30
Sep
Dr. Bérard received a new grant from the Canadian Institutes for Health Research (CIHR) to perform a case-control study on mother-to-child transmission of HIV during pregnancy. Three outcomes of maternal HIV will be assessed: 1) mother-baby transmission; 2) congenital malformations; and 3) neonatal deaths. This study will be conducted using two Canadian databases (the Quebec Pregnancy Cohort and the Saskatchewan database) and an American database (US Medicaid Cohort).
